Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Voice ; 30(3): 281-6, 2016 May.
Article in English | MEDLINE | ID: mdl-25953587

ABSTRACT

OBJECTIVE: To analyze the voice formants (F1, F2, F3, and F4 in Hz) of seven oral vowels, in Brazilian Portuguese, [a, ε, e, i, ɔ, o, and u] in adult individuals with congenital lifetime untreated isolated growth hormone deficiency (IGHD). STUDY DESIGN: This is a cross-sectional study. METHODS: Acoustic analysis of isolated vowels was performed in 33 individuals with IGHD, age 44.5 (17.6) years (16 women), and 29 controls, age 51.1 (17.6) years (15 women). RESULTS: Compared with controls, IGHD men showed higher values of F3 [i, e, and ε], P = 0.006, P = 0.022, and P = 0.006, respectively and F4 [i], P = 0.001 and lower values of F2 [u], P = 0.034; IGHD women presented higher values of F1 [i and e] P = 0.029 and P = 0.036; F2 [ɔ] P = 0.006; F4 [ɔ] P = 0.031 and lower values of F2 [i] P = 0.004. IGHD abolished most of the gender differences in formant frequencies present in controls. CONCLUSIONS: Congenital, severe IGHD results in higher values of most formant frequencies, suggesting smaller oral and pharyngeal cavities. In addition, it causes a reduction in the effect of gender on the structure of the formants, maintaining a prepubertal acoustic prediction.


Subject(s)
Dwarfism, Pituitary/physiopathology , Human Growth Hormone/deficiency , Speech Acoustics , Voice Quality , Acoustics , Adult , Aged , Biomarkers/blood , Brazil , Case-Control Studies , Cross-Sectional Studies , Dwarfism, Pituitary/blood , Dwarfism, Pituitary/diagnosis , Dwarfism, Pituitary/genetics , Female , Human Growth Hormone/blood , Humans , Male , Middle Aged , Mouth/growth & development , Pharynx/growth & development , Severity of Illness Index , Sex Factors , Speech Production Measurement
2.
J Voice ; 26(5): 673.e13-9, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22698553

ABSTRACT

OBJECTIVE: The aim of this study was to analyze the individual impact of short stature (SS) or untreated isolated growth hormone deficiency (IGHD) on voice quality and the influence of IGHD on voice aging. METHODS: A cross-sectional study was carried out on 73 adults: 33 IGHD, 10 SS, and 30 normal controls (CO), by evaluating vocal perception using Voice-Related Quality-of-Life (V-RQOL) scores and fundamental frequency (ƒ0). Analysis of variance with Bonferroni post-test was used to compare groups, and the Student t test was used to verify the influence of aging. RESULTS: Stature of the SS and IGHD groups was similarly reduced in comparison to CO. Cephalic perimeter (CP) in SS males was larger than CO (P<0.05), and this was larger than in IGHD (P<0.0001). CP was similar in SS and CO females, and both were larger than in IGHD (P<0.0001). V-RQOL scores were lower in IGHD than in SS and CO. ƒ0 (Hz) was similar in IGHD females and SS and higher than in CO (P<0.05). f0 of IGHD males was higher than in SS (P=0.01) and CO (P=0.001). IGHD abolished the effect of aging on ƒ0 exhibited by CO. CONCLUSIONS: Lower vocal perception and higher ƒ0 were found in IGHD in comparison to CO in both genders; in comparison to SS, higher ƒ0 was only found in IGHD males. Because SS males have higher CP than IGHD, this suggests that CP and craniofacial growth can influence voice in IGHD. Finally, IGHD seems to abolish the effects of aging on voice.


Subject(s)
Body Height , Dwarfism, Pituitary/physiopathology , Human Growth Hormone/deficiency , Voice Quality , Acoustics , Adult , Age Factors , Analysis of Variance , Case-Control Studies , Cross-Sectional Studies , Dwarfism, Pituitary/blood , Dwarfism, Pituitary/psychology , Emotions , Female , Human Growth Hormone/blood , Humans , Male , Middle Aged , Quality of Life , Sex Factors , Surveys and Questionnaires
3.
Dig Dis Sci ; 50(5): 949-54, 2005 May.
Article in English | MEDLINE | ID: mdl-15906774

ABSTRACT

Since new molecules that normally would accelerate regeneration can also be potentialized by light, the use of new substances combined with laser therapy seems to be a natural type of experiment. Therefore, the purpose of this study was to assess the effects of Hyptis pectinata leaves on liver regeneration after partial hepatectomy (PH) associated with laser therapy. Twenty-four rats were divided into four groups--PH(control), PHL (laser therapy), PH200 (200 mg/kg of Hyptispectinata), and PHL200 (200 mg/kg of the plant and laser)--which were submitted to 67% hepatectomy. Laser treatment consisted of focusing the light on the remaining liver after hepatectomy. The data analyzed were serum levels of aminotransferases, liver regeneration, and mitochondrial function. Group PH200 showed a statistically significant decrease in AST levels, and PHL200 disclosed an augmentation in ALT levels. The liver regeneration index was significantly increased in group PHL200. Concerning liver mitochondrial respiratory assay, groups PH200 and PHL200 showed lower state 3 levels than groups PH and PHL. Group PHL showed an increase in state 4 levels and a reduction in membrane potential and RCR. The present study shows that the association of the aqueous extract of Hyptis pectinata leaves at 200 mg/kg with intraoperative laser therapy can stimulate liver regeneration and cause a reduction in liver mitochondrial respiratory function without altering its phosphorylative activity.


Subject(s)
Hyptis , Liver Regeneration/drug effects , Liver Regeneration/radiation effects , Low-Level Light Therapy , Animals , Hepatectomy , Male , Mitochondria, Liver/drug effects , Mitochondria, Liver/physiology , Mitochondria, Liver/radiation effects , Phytotherapy , Plant Extracts/pharmacology , Plant Leaves , Rats , Rats, Wistar , Transaminases/blood , Transaminases/drug effects , Transaminases/radiation effects
4.
J Surg Res ; 121(1): 108-11, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15313383

ABSTRACT

BACKGROUND: A prospective study was carried out to evaluate the results of distal splenorenal shunt (DSRS) with or without splenic artery ligation (SAL) in patients with schistosomal portal hypertension. MATERIALS AND METHODS: Thirty patients were divided into two groups: 15 were submitted to DSRS (Group I) and the other 15 were submitted to DSRS + SAL (Group II). They were observed for 24 months. Clinical and laboratory features were analyzed. RESULTS: There was neither mortality nor clinical manifestation of portosystemic encephalopathy in both groups. Recurrent hemorrhage and thrombosis incidence had no statistical difference. Although patients in Group II presented higher levels of postoperative pain and fever, spleen size reduction was higher than in Group I. White blood cells and platelets were increased in patients who underwent DSRS + SAL, even though there was no statistically significant difference between the groups. An increase in bilirubin was observed on the first postoperative day. Arterial blood ammonia and liver function were similar in both groups. Endoscopic control showed reduction in size of varices or their disappearance in 80 and 93% of patients from Groups I and II, respectively. CONCLUSIONS: Although SAL associated with DSRS was responsible for increasing postoperative morbidity, it did not increase the incidence of shunt thrombosis and improved white blood cells and platelets count as well as reduced the spleen size. Therefore, the authors believe that SAL associated with DSRS is an effective treatment for schistosomal portal hypertension. Besides, it should be performed when a large spleen and hypersplenism are present.


Subject(s)
Hypertension, Portal/surgery , Schistosomiasis/complications , Splenic Artery/surgery , Splenorenal Shunt, Surgical , Humans , Ligation , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL